Half body radiotherapy in the management of metastatic carcinoma of the prostate.
Half body radiation has proved to be an effective method of pain relief in the management of metastatic carcinoma of the prostate. Seventy-two per cent of the patients respond. The median response is 4.7 months and the median survival is 5.5 months. Since the procedure requires only 2 hospital admissions of approximately 48 hours it provides an efficient use of health resources.
D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis / Q000532:radiotherapy*; D011471:Prostatic Neoplasms / Q000532:radiotherapy*